Detalles de la búsqueda
1.
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Lancet
; 399(10328): 905-907, 2022 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090602
2.
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.
Cancer Cell
; 41(5): 821-823, 2023 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37116490
3.
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Cell Rep Med
; 3(10): 100781, 2022 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36240755
4.
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2.
Nat Med
; 27(8): 1362-1366, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34040262
5.
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.
Cancer Cell
; 39(11): 1497-1518.e11, 2021 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34715028
6.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
Nat Cancer
; 2: 1321-1337, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34950880
7.
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Res Sq
; 2021 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34580668
8.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Nat Cancer
; 2(12): 1305-1320, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121899
9.
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
; 40(4): 438, 2022 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35413273
10.
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
; 40(2): 114-116, 2022 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34968417
Resultados
1 -
10
de 10
1
Próxima >
>>